Found: 7
Select item for more details and to access through your institution.
L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Changes in the tumour microenvironment mark the transition from serous borderline tumour to low‐grade serous carcinoma.
- Published in:
- Journal of Pathology, 2024, v. 264, n. 2, p. 197, doi. 10.1002/path.6338
- By:
- Publication type:
- Article
Mesonephric‐like adenocarcinoma harbours characteristic copy number variations and a distinct DNA methylation signature closely related to mesonephric adenocarcinoma of the cervix.
- Published in:
- Journal of Pathology, 2024, v. 262, n. 1, p. 4, doi. 10.1002/path.6217
- By:
- Publication type:
- Article
Cellular context determines DNA methylation profiles in SWI/SNF‐deficient cancers of the gynecologic tract.
- Published in:
- Journal of Pathology, 2022, v. 257, n. 2, p. 140, doi. 10.1002/path.5889
- By:
- Publication type:
- Article
Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis‐associated ovarian carcinomas.
- Published in:
- Journal of Pathology, 2022, v. 256, n. 4, p. 388, doi. 10.1002/path.5849
- By:
- Publication type:
- Article
Mesonephric‐type adenocarcinomas of the ovary: prevalence, diagnostic reproducibility, outcome, and value of PAX2.
- Published in:
- Journal of Pathology: Clinical Research, 2024, v. 10, n. 4, p. 1, doi. 10.1002/2056-4538.12389
- By:
- Publication type:
- Article
Endometrial stromal sarcomas with BCOR‐rearrangement harbor MDM2 amplifications.
- Published in:
- Journal of Pathology: Clinical Research, 2020, v. 6, n. 3, p. 178, doi. 10.1002/cjp2.165
- By:
- Publication type:
- Article